TXNIP and breast cancer: TXNIP can also negatively regulate the progression of bladder carcinogenesis (BC) by inhibiting the extracellular signal-regulated kinase (ERK) induced by stromal cell-derived factor 1 or CXC chemokine receptor type 4 [128].